About Hi Tech and Global Research LLC
Clinical Trials at Hi Tech and Global Research LLC
During the past decade, Hi Tech and Global Research LLC conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hi Tech and Global Research LLC" #1 sponsor was "Shire" with 5 trials, followed by "Intercept Pharmaceuticals" with 1 trials
sponsored, "Inventiva Pharma" with 1 trials sponsored, "Mylan Inc." with 1 trials sponsored and "Tobira Therapeutics, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hi Tech and Global Research LLC"
#1 collaborator was "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hi Tech and Global Research LLC
According to Clinical.Site data, the most researched conditions in "Hi Tech and Global Research LLC" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Compensated Cirrhosis" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Hi Tech and Global Research LLC" in a lesser frequency.
Clinical Trials Intervention Types at Hi Tech and Global Research LLC
Most popular intervention types in "Hi Tech and Global Research LLC" are "Drug" (8 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ontamalimab" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Cenicriviroc" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hi Tech and Global Research LLC
The vast majority of trials in "Hi Tech and Global Research LLC" are
9 trials for "All" genders.
Clinical Trials Status at Hi Tech and Global Research LLC
Currently, there are NaN active trials in "Hi Tech and Global Research LLC".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hi Tech and Global Research LLC,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Hi Tech and Global Research LLC, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".